Please assess the completion status of the following clinical trial:

Trial Title: The Impact and Cost-effectiveness of Safer Conception Strategies for HIV-discordant Couples (SAFER)

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~For all couples:~* Couple expresses a desire to conceive~* Sexually active (defined as having vaginal sex with one another at least 6 times in the past 3 months~* Willing to enter the study as a couple and intending to remain as a couple and have a sexual relationship for the next 12 months~* Willing to use at least one safer conception strategy~* For men, age ≥18 years. For women, age 18 - 35 years;~* Able and willing to provide written informed consent~For HIV-uninfected members of the couple~* HIV-negative based on parallel negative HIV rapid tests, both at study screening and enrollment visit~* Adequate renal function, defined by normal creatinine levels and estimated creatinine clearance ≥60 mL/min~For HIV-infected members of the couple~* HIV-positive based on parallel positive HIV rapid tests, based on national algorithm~* No current AIDS-defining illness~Exclusion Criteria:~* Amenorrheic~* Currently pregnant~* Active and serious infections, including active tuberculosis infection; active clinically significant medical problems including cardiac disease, pulmonary disease, and previously diagnosed malignancy expected to require further treatment.~* History of infertility defined as a year or more of regular unprotected intercourse with current partner without pregnancy, or otherwise medically diagnosed infertility~* Currently on any concomitant medication that requires the participant to avoid use of PrEP

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 35 Years
- Healthy Volunteers: t

Study Arms:
- HIV+male/HIV-female (Type: None): discordant couple given the choice of using at least one of the following: Antiretrovirals, PrEP (Truvada), or semen washing
- HIV+female/HIV-male (Type: None): discordant couple given the choice of using at least one of the following: Antiretrovirals, PrEP (Truvada), or artificial vaginal insemination

Based on this trial design, predict the completion outcome and termination type (if applicable).